Engineering a patient’s own immune cells to resist HIV could eliminate the need for lifelong antiretroviral therapies.
Tailor-made medical devices could give a more detailed picture of cardiac health and may be better at predicting and preventing problems.
Artificial tissue has always lacked a key ingredient: blood vessels. A new 3-D printing technique seems poised to change that.
By tracking an older person’s movements at home, a new wearable device could help predict serious changes in health.
A single-molecule gene test requires much less DNA to identify cancer-causing mutations.
Researchers find a way to turn pain on, and off, with a beam of light.
A new nerve interface gives a sense of touch to a prosthetic limb.
These VCs don’t wait for biotech startups to come to them. They create companies themselves.
After outflanking and outlasting competitors, it is on top of the genome-sequencing business—just as that market is about to soar in importance.
Precise and easy ways to rewrite human genes could finally provide the tools that researchers need to understand and cure some of our most deadly genetic diseases.